Ming C. Yeung
30Patents
6h-index
104Co-inventors
72Inventor score
Filing activity: Aug 16, 1996 → May 19, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6455571B1 | Inhibitors of neuraminidases | Chemistry; Metallurgy | 48 | Expired |
| US9981910B2 | Substituted pyrrolidines and methods of use | Chemistry; Metallurgy | 28 | Active |
| US10118916B2 | Modulators of cystic fibrosis transmembrane conductance regulator protein | Chemistry; Metallurgy | 26 | Active |
| US5696084A | Amino-lipopetide antifungal agents | Human Necessities | 24 | Expired |
| US7517876B2 | Anti-infective agents | Chemistry; Metallurgy | 13 | Expired |
| US7378414B2 | Anti-infective agents | Chemistry; Metallurgy | 9 | Expired |
| US8129417B2 | Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers | Human Necessities | 5 | Active |
| US5789591A | Process for preparing 1-substituted 8-chloro-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid ethyl ester compounds | Chemistry; Metallurgy | 4 | Expired |
| US9642831B2 | Substituted chromanes and method of use | Chemistry; Metallurgy | 3 | Active |
| US8937041B2 | Macrocyclic hepatitis C serine protease inhibitors | Human Necessities | 2 | Active |
| US9567322B2 | Substituted tetrahydropyrans and method of use | Human Necessities | 2 | Active |
| US10399940B2 | Substituted pyrrolidines and methods of use | Chemistry; Metallurgy | 1 | Active |
| US8691865B2 | Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers | Chemistry; Metallurgy | 1 | Active |
| US7834043B2 | HIV protease inhibiting compounds | Chemistry; Metallurgy | 1 | Active |
| US6518305B1 | Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases | Chemistry; Metallurgy | 1 | Expired |
| US6831096B2 | Inhibitors of neuraminidases | Chemistry; Metallurgy | 1 | Expired |
| US8796470B2 | Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators | Human Necessities | 0 | Active |
| US8653141B2 | HIV protease inhibiting compounds | Chemistry; Metallurgy | 0 | Active |
| US7902203B2 | Anti-infective agents | Chemistry; Metallurgy | 0 | Expired |
| US8497275B2 | HCV protease inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US7696226B2 | HIV protease inhibiting compounds | Chemistry; Metallurgy | 0 | Active |
| US10981890B2 | Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10428017B2 | Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10844041B2 | Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10988454B2 | Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.